Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Ziyu Biotechnology, commonly referred to as ZiYuPeptides, appears to be a private China-based peptide manufacturing and supply company focused on research-use and custom peptide products. Publicly available third-party listings describe the company as a high-tech enterprise in biotechnology and life sciences and a manufacturer of peptide products, with offerings spanning catalog peptides and custom synthesis. Its business seems oriented toward supplying peptides and related materials for research and pharmaceutical development rather than advancing a disclosed proprietary therapeutic pipeline. Available evidence points to commercial operations in Shanghai, China through the website ziyupeptides.com. Because primary-source company information is limited and the corporate website is not accessible via browsing tools, several fields below should be treated as best-effort estimates based on secondary sources.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZiYuPeptides.